Los Angeles, CA
The Food and Drug Administration (FDA) has just approved a new treatment developed by the Los Angeles Biomedical Research Institute that will improve the lives of many patients who suffer from Sickle Cell Anemia.
Sickle Cell is a painful blood disorder that primarily affects people of African descent. Until now, treatment for the condition involved medications that include a long list of debilitating side-effects. The drug developed by the LA Biomedical Research Institute, called Endari, is the first drug ever approved for the treatment of sickle cell anemia in children, and the first drug in twenty years approved for the treatment of sickle cell anemia in adults, according to a report by ABC News.